| scholarly article | Q13442814 |
| P50 | author | Kelvin Chong | Q45933657 |
| Terry J. Smith | Q45933677 | ||
| Raymond S Douglas | Q51353730 | ||
| P2093 | author name string | Nikoo F Afifiyan | |
| Andrew G Gianoukakis | |||
| Catherine J Hwang | |||
| Patrick Richards | |||
| Uzma Haider | |||
| P2860 | cites work | Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus | Q24561889 |
| Key apoptotic pathways for heat-induced programmed germ cell death in the testis | Q28574219 | ||
| Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
| The role of CXC chemokines in pulmonary fibrosis | Q30443091 | ||
| A novel mouse model of Graves' disease: implications for a role of aberrant MHC class II expression in its pathogenesis | Q34112895 | ||
| Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells | Q34148399 | ||
| Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma | Q34207374 | ||
| Immune function of thyroid stimulating hormone and receptor. | Q34581191 | ||
| Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy | Q34599712 | ||
| Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy | Q34599722 | ||
| Novel functions of the CD34 family | Q34873662 | ||
| TNFalpha mediates the skeletal effects of thyroid-stimulating hormone | Q35036487 | ||
| Regulation of lipolysis during the neonatal period. Importance of thyrotropin | Q35593693 | ||
| Physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tissues other than the thyroid | Q35605723 | ||
| Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications. | Q35646567 | ||
| Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue | Q72226506 | ||
| Thyroid-stimulating immunoglobulins | Q72541493 | ||
| TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease | Q72571300 | ||
| Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue | Q73515509 | ||
| Cytokine-induced lymphocyte chemoattraction from cultured human thyrocytes: evidence for interleukin-16 and regulated upon activation, normal T cell expressed, and secreted expression | Q73536736 | ||
| Human thyroid fibroblasts exhibit a distinctive phenotype in culture: characteristic ganglioside profile and functional CD40 expression | Q73923154 | ||
| Peripheral blood fibrocytes: differentiation pathway and migration to wound sites | Q73966720 | ||
| Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts | Q74061122 | ||
| Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy | Q74324679 | ||
| Sentinel node biopsy for orbital and ocular adnexal tumors | Q74760558 | ||
| An intrinsic thyrotropin-mediated pathway of TNF-alpha production by bone marrow cells | Q78410308 | ||
| Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues | Q78589378 | ||
| TSH Is a Negative Regulator of Skeletal Remodeling | Q79184844 | ||
| Thyrotropin receptor knockout mice: studies on immunological tolerance to a major thyroid autoantigen | Q79313802 | ||
| Circulating fibrocytes: collagen-secreting cells of the peripheral blood | Q35686362 | ||
| Advances in applied anatomy of the eyelid and orbit | Q35996567 | ||
| The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ | Q36183661 | ||
| The role of circulating fibrocytes in fibrosis | Q36434149 | ||
| Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair | Q36437461 | ||
| Fibrocytes in lung disease | Q36841197 | ||
| Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. | Q36951623 | ||
| Circulating fibrocytes: cellular basis for NSF. | Q37052273 | ||
| CD34+ fibrocytes: morphology, histogenesis and function | Q37066604 | ||
| Bone marrow cells produce a novel TSHbeta splice variant that is upregulated in the thyroid following systemic virus infection | Q37069161 | ||
| Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation | Q37114625 | ||
| Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule | Q37309918 | ||
| Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. | Q37417167 | ||
| Connective tissue, glycosaminoglycans, and diseases of the thyroid | Q38688493 | ||
| Stressful life events in the pathogenesis of Graves' disease | Q39428143 | ||
| Immunological responses in the eyelid and orbit | Q39545127 | ||
| Interaction between Thyroid-Stimulating Immunoglobulins and Thyrotropin Receptors in Fat Cell Membranes* | Q40260117 | ||
| Interleukin-6 is a direct mediator of T cell migration | Q40515648 | ||
| Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy | Q40893670 | ||
| Long-term follow-up of Graves ophthalmopathy in an incidence cohort | Q40994540 | ||
| Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies | Q42460915 | ||
| Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts | Q43845891 | ||
| Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy | Q43853007 | ||
| Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes | Q43867818 | ||
| Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. | Q45096631 | ||
| IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. | Q45981776 | ||
| Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway | Q46107628 | ||
| Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma | Q46224631 | ||
| The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes | Q46713511 | ||
| Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. | Q50580688 | ||
| The thyrotropin (thyroid-stimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD45RBhigh lymph node T cells: functional role for thyroid-stimulating hormone during immune activation. | Q52026610 | ||
| Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. | Q53611171 | ||
| Characterization of a novel set of resident intrathyroidal bone marrow-derived hematopoietic cells: potential for immune-endocrine interactions in thyroid homeostasis. | Q54740671 | ||
| Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease | Q68522996 | ||
| Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells | Q70233713 | ||
| Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts | Q72055491 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 430-438 | |
| P577 | publication date | 2009-11-06 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Increased generation of fibrocytes in thyroid-associated ophthalmopathy | |
| P478 | volume | 95 |
| Q92462109 | An assessment of the ocular tear film in patients with thyroid disorders |
| Q64285170 | Bioinformatic Analysis Identifies Potentially Key Differentially Expressed Genes and Pathways in Orbital Adipose Tissues of Patients with Thyroid Eye Disease |
| Q38207992 | Biological Impact of the TSHβ Splice Variant in Health and Disease |
| Q55072649 | CD34- Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-α Expression in CD34+ Fibroblasts and Fibrocytes. |
| Q54784068 | CD34-positive fibroblasts in Reinke's edema. |
| Q36133982 | CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation |
| Q27691806 | Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. |
| Q34763844 | Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside. |
| Q36982003 | Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation |
| Q37286476 | Effect of Thyrotropin on Osteopontin, Integrin αvβ3, and VCAM-1 in the Endothelium via Activation of Akt. |
| Q51370817 | Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy. |
| Q33837137 | Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. |
| Q35597978 | Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease. |
| Q28085703 | Fibrocytes at 20 Years |
| Q89613159 | Fibrocytes in the Tumor Microenvironment |
| Q39634075 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q36690680 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q35983102 | Human fibrocytes coexpress thyroglobulin and thyrotropin receptor |
| Q33569105 | Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases |
| Q47259453 | IGF-I receptor and thyroid-associated ophthalmopathy |
| Q34421826 | Immunological regulation of metabolism--a novel quintessential role for the immune system in health and disease |
| Q35054706 | Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation. |
| Q35921354 | Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. |
| Q92691246 | Infiltrating CCR2+ monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1 |
| Q36422528 | Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. |
| Q41640757 | Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy |
| Q90610791 | Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy" |
| Q58579926 | Molecular biomarkers of Graves' ophthalmopathy |
| Q28596143 | Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases |
| Q55024151 | New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor. |
| Q92335694 | New insights into the pathogenesis and nonsurgical management of Graves orbitopathy |
| Q64236637 | Novel Splicing of Immune System Thyroid Stimulating Hormone β-Subunit-Genetic Regulation and Biological Importance |
| Q28730668 | Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17 |
| Q37296579 | Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype |
| Q35153361 | Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA |
| Q34131044 | PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN |
| Q37772737 | Pathogenesis of Graves' orbitopathy: a 2010 update. |
| Q36164346 | Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts. |
| Q27005680 | Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment |
| Q93177163 | Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy |
| Q37775693 | Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy. |
| Q33862408 | Proliferation of Interstitial Cells in the Cyclophosphamide-Induced Cystitis and the Preventive Effect of Imatinib. |
| Q33778092 | Rationale for therapeutic targeting insulin-like growth factor-1 receptor and bone marrow-derived fibrocytes in thyroid-associated ophthalmopathy |
| Q37681137 | Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts. |
| Q90636934 | Response to Letter to the Editor: "Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy" |
| Q35443741 | Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells |
| Q37017174 | Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. |
| Q37603432 | STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia |
| Q89838042 | Slit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes |
| Q64996955 | Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease. |
| Q26749195 | THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy |
| Q35667567 | TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist |
| Q36393011 | TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy |
| Q34556184 | Teprotumumab for Thyroid-Associated Ophthalmopathy. |
| Q34130987 | Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. |
| Q52589503 | The emerging role of fibrocytes in ocular disorders. |
| Q36439938 | The pathophysiology of thyroid eye disease: implications for immunotherapy. |
| Q92157970 | The role of cell mediated immunopathogenesis in thyroid-associated ophthalmopathy |
| Q26829700 | The role of circulating fibrocytes in inflammation and autoimmunity |
| Q89843708 | Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy |
| Q46870418 | Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy. |
| Q34525298 | Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis) |
| Q38312223 | Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions. |
| Q37060099 | Update on advanced imaging options for thyroid-associated orbitopathy |
| Q33802192 | Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface |
Search more.